Nab-paclitaxel plus S-1 versus oxaliplatin plus S-1 as first-line treatment in advanced gastric cancer: results of a multicenter, randomized, phase III trial (GAPSO study)
暂无分享,去创建一个
H. Qiu | Q. Fu | Mingsheng Zhang | L. Zhuang | Y. Zou | Yuhong Dai | Huiting Xu | Xiong-Jie Yu | Xiang-Lin Yuan | Zhuang Liang